Agilent Deploys Next Generation Explosive Detection System at London Heathrow Airport
November 29, 2022
Innovative Insight200M liquid explosive detection system will further increase airport security and safety, and speed up passenger throughput SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the deployment of the next generation of alarm resolution technology for checkpoints throughout London Heathrow airport, delivering advanced security and efficiency. The Insight200M from Agilent ensures increased [...]
November 29, 2022
Offers Insight for Drug Discovery Related to Diabetes, Cholesterol Management, and Obesity STATE COLLEGE, Pa. -- Today INDIGO Biosciences announced the release of a new cell-based luciferase reporter assay for the Human G Protein-Coupled Bile Acid Receptor 1 (GPBAR1; TGR5). TGR5 is a bile acid membrane receptor of the GPCR family and is encoded by [...]
November 29, 2022
BOSTON -- TetraScience, the Scientific Data Cloud company, announced today that Virscidian, provider of analytical processing software, has joined the Tetra Partner Network to help customers automate and accelerate workflows in biopharmaceutical research and development by utilizing the Tetra Scientific Data Cloud™. "Virscidian has built a range of tools that enhance method development, and automate the review and [...]
CPI Enterprises investment in BiologIC
November 28, 2022
BiologIC Technologieshas received an investment from CPI Enterprises. CPI is a recognised leader in bioprocessing innovation founded with a clear vision - to stimulate impactful investment into deep technology businesses. Cambridge UK: BiologIC Technologies ("BiologIC"), the biocomputer company, announces today that it has received an investment from CPI Enterprises. BiologIC is the inventor of the [...]
Two Industry Veterans Join Already Strong Team
November 28, 2022
MENLO Park – LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of Global Commercial Operations of LevitasBio Europe BV, and the appointment of Greg Herrema to its Board of Directors. The addition of two Life Sciences [...]
November 28, 2022
Image: Overview: The Applied Biosystems 3500 Dx Genetic Analyzer and Applied Biosystems 3500xL Dx Genetic Analyzer are mid-throughput capillary electrophoresis (CE)-based in vitro diagnostic devices designed to perform fluorescence-based sequencing and fragment analysis of nucleic acids in human-derived specimens. IVDR-compliant versions of [...]
Aptamer Group opens new state-of-the-art laboratories
November 28, 2022
- The new facilities will support the increased demand for Optimer technology - Baroness Susan Greenfield opened the new site and presented on the challenges in scientific discovery York, UK – Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has opened its new facilities [...]
November 28, 2022
Acquisition adds isotachophoresis (ITP), a proprietary technology licensed exclusively from Stanford University and developed by Purigen Biosystems for isolation and purification of nucleic acids, to the arsenal of tools for potentially simplifying ultra high molecular weight (UHMW) DNA isolation and purification for optical genome mapping (OGM) with more consistency at scale Adds the Ionic® Purification System, a [...]
November 28, 2022
Shimadzu and Kyoto University have signed a three-year comprehensive collaborative agreement with the objective of creating new business activities by acquiring innovative technologies to contribute to solving social problems, and training human resources in the social implementation of these new business activities. Both parties have previously engaged in a number of collaborative research projects, and [...]
November 25, 2022
Caption: Cell Media and DMSO-Free Cryopreservation Solutions. BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors.Suitable for Cell Therapy applications at any stage, the portfolio of cell media products include [...]

